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Although  idiotypic dominance  was first observed over a  decade ago  in  the 
antiarsonate (ABA) 1 system (1), its mechanism remains enigmatic. It was initially 
postulated that B cell clones expressing a dominant idiotype were preferentially 
expanded because they had higher affinities for antigen than their less successful 
competitors (2). Subsequent studies (2) showed, however, that anti-ABA antibod- 
ies  expressing  a  dominant  idiotype  had  median  affinities  for  ABA,  arguing 
persuasively against this explanation.  Recent work suggests that multiple mech- 
anisms may be responsible for idiotypic dominance. 
Idiotypic dominance may be established at different levels in B cell ontogeny. 
In the T15 system, dominance has been demonstrated as early as the pre-B cell 
stage (3). In other responses, including that of A strain mice to ABA, dominance 
is established only after the expression  of surface immunoglobulin  (4).  In  this 
system,  CRI  "+ (cross-reactive idiotope) B  cells accounted for ~3%  of the  total 
number of B cells responding to ABA in nonimmune mice. Upon immunization, 
this frequency increased to 20-80%  (4), suggesting that the CRI  a+ B cells were 
preferentially expanded. Since this observation cannot be directly accounted for 
by differences in affinity (2), idiotype-specific selection is implicated. 
Idiotype-specific regulation could establish idiotypic dominance by either pos- 
itive  or  negative  selection  of particular  B  cell  clones.  Dominance  by positive 
selection could result from idiotype-specific helper T  cells preferentially expand- 
ing clones that express a particular idiotype. Such helper cells have been reported 
in the CRI" (5) and other systems (6,  7).  Alternatively, dominance could result 
This was supported by grants AI-17090 and AI-05664. Current address of P. Hornbeck is National 
Institute of Allergy and Infectious Diseases, Laboratory of Immunology, Bethesda, MD 20205. 
Current address of G. Lewis  is University of Maryland, Department of Microbiology,  Baltimore, MD 
21201. He is the recipient of American Cancer Society  Faculty  Research Award FRA-264. 
J  Abbreviations used in this paper:  ABA,  p-azobenzenearsonate; ABP, p-azobenzenephosphonate; 
BSA, bovine  serum albumin; CFA, complete Freund's adjuvant; CGG, chicken gamma-globulin; CR1, 
cross-reactive idiotope; D segment, diversity segment; DANS, dansyl; ELISA, enzyme-linked immu- 
nosorbent assay; FL, fluorescein; JH, joining segment; KLH, keyhole limpet hemocyanin; mAb, 
monoclonal antibody; MHC, major histocompatibility  complex; 4-MUP, 4-methyl-umbellifferyl  phos- 
phate; NPP, p-nitrophenly phosphate; OVA, ovalbumin; PC,  phosphoryl choline; RGG, rabbit 
gammaglobulin; TNP, trinitrophenyl; VH region, heavy  chain variable region; VL, light chain variable 
region. 
J. ExP. MED. © The Rockefeller  University  Press • 0022-1007/85/1/0053/19 $1.00  53 
Volume 161  January 1985  53-71 54  IDIOTYPIC DOMINANCE IN  THE ANTIARSONATE RESPONSE 
from negative selection by preferentially suppressing cells that lack the dominant 
idiotype. In this case, idiotypes become dominant because they do not stimulate 
endogenous antiidiotypic suppressor  activity. Such  mechanisms are  consistent 
with reports (8-10)  that T  and  B cell antiidiotypic suppression play a  role in 
limiting clonal expansion. 
The idiotope CRI  M~, a  member of the CRU family, dominates the response 
of A  strain  mice  to  ABA  (11).  If this  dominance is  due  to  idiotype-specific 
regulation,  then  responses  to  other  antigens  that  use  CRI  ADs  might also  be 
dominated by  this  idiotope.  Testing this hypothesis requires  identification of 
antigens, other than ABA, which elicit CRI  An8. We recently reported (11)  that 
CRI  M~8 is expressed on naturally occurring antibodies not specific for ABA. It 
was found on 0.1-0.5%  of the naturally occurring antibodies in every A strain 
mouse  studied,  showing  that  this  idiotope  is  frequently used  in  response  to 
antigens  other  than  ABA.  Unfortunately, it  was  not  possible  to  define  the 
specificities of the naturally occurring idiotope, making it impossible to test the 
above  hypothesis.  Nevertheless,  the  recurrence  of CRI  An8  on  antibodies  not 
specific for ABA suggested that this idiotope might be found on antibodies in 
diverse anti-hapten responses. 
This suggestion was borne out in the studies described below, where we look 
at the dominance of CRI  ADs in antibody responses elicited by several haptenic 
groups  and  a  single  protein.  Immunization  with  trinitrophenyl  (TNP),  and 
chicken gammaglobulin (CGG), but not with fluorescein (FL), azobenzenephos- 
phonate (ABP), and dansyl (DANS), elicited significant levels of CRI  A°8, but in 
neither of these responses was it dominant. Attempts to increase CRI  ADs in anti- 
TNP responses by immunizing with double conjugates of TNP and ABA on the 
same carrier, failed. Analysis of hybridoma proteins and DNA showed the CRI  An8 
correlates with the heavy chain variable (VH)  2 and diversity (D) segments used 
by  the  prototypic  CRU  antibodies,  but  does  not  correlate  with  heavy chain 
joining (Jn) or Vt. (light chain variable) segments (12,  13, 40, 54-56). Together, 
these observations suggest that VH regions which contain CRI  An8 are necessary, 
but  not  sufficient for  dominance;  an  additional  specificity may be  required. 
Subsequent studies showed that  immunization with  ABA calls  up  ABP-cross- 
reactive antibodies expressing CRI  ADS, but that immunization with ABP fails to 
elicit CRI  A~8, even on ABA-cross-reactive antibodies. These results are consistent 
with ABA itself being the additional specificity. 
Materials and Methods 
Animals.  Female A/J mice,  6-8 wk old, were purchased from The Jackson Laboratory, 
Bar Harbor, ME and used after acclimatization to our animal colony. 
Proteins and Antigens.  Bovine serum albumin (BSA) was purchased from Sigma Chem- 
ical Co., St.  Louis, MO.  CGG was prepared from chicken serum  (Gibco Laboratories, 
Santa Clara, CA) by successive ammonium sulfate precipitations.  Keyhole limpet hemo- 
cyanin  (KLH) was  purchased  from Calbiochem-Behring  Corp.,  San  Diego,  CA  (No. 
374805). Rabbit gammaglobulin (RGG) was purchased from Miles Laboratories, Elkhart, 
IN (No. 824551). Chicken ovalbumin (OVA) was purchased  from Schwarz/Mann  Div., 
Becton, Dickinson & Co., Orangeburg, NY. (No. 7819239). 
2 "v. region" refers to the entire heavy chain variable region and includes the V., D, and J. 
segments. "VH segment"  refers only  to the region encoded  by the VH gene and includes  positions 1- 
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ABA-conjugated proteins were prepared from p-aminobenzenearsonic acid (No. 1369; 
Eastman  Kodak Co.,  Rochester, NY) according to Tabachnik and Sobotka (14).  ABP 
proteins were conjugated identically to the ABA proteins, except that p-aminobenzene- 
phosphonic acid, synthesized by Dr. D. E. Nitecki, was used instead ofp-aminobenzenear- 
sonic acid. Proteins were reacted with dansyl chloride (No. D-2625; Sigma Chemical Co.) 
according to standard procedures (15). FL-modified proteins were prepared with fluores- 
cein isothiocyanate (No.  F-7250;  Sigma Chemical Co.) according to Wofsy et al.  (16). 
Proteins  were  coupled  with  TNP  using  trinitrobenzene-sulfonic acid  (P-5878~  Sigma 
Chemical Co.) as described by Good et al. (17). The bisubstituted carrier TNP-ABA-KLH 
was prepared by conjugating TNP-KLH with ABA as described above. 
Haptens.  TNP-iysine was from Sigma Chemical Co. (D-0380), and ABA-tyrosine was 
from Biosearch, San Rafael, CA. 
Antisera.  Mice  were  primed  with  0.1  mg  antigen  in  0.15  ml  complete  Freund's 
adjuvant (CFA) and boosted 21 d later with 0.1 mg antigen in 0.15 ml incomplete Freund 
adjuvant. We collected antisera by tail-bleeding mice 7 d after immunization. Hyperim- 
mune ascites against TNP-ABA-KLH and TNP-KLH were prepared as described (18). 
Preparation of lmmunoadsorbents.  Biogel A-1.5 m (Bio-Rad Laboratories, Richmond, 
CA) or Sepharose 4B (Pharmacia, Inc., Uppsala, Sweden) were activated with CNBr (19) 
and coupled with AD8, ABA-BSA, ABP-BSA, DANS-BSA, FL-BSA, TNP-BSA, or TNP- 
OVA. >95% of the input protein was coupled to the activated matrix. The final coupling 
densities  were  usually  around  5  mg  protein/ml  gel.  ABA-tyraminyl-Affigel-10 was 
prepared from Affigel-10 (Bio-Rad Laboratories). 
Antibody Purification.  Specific antibodies were purified from sera, ascites, or hybridoma 
supernatants on affinity columns containing the immunizing protein or hapten conjugated 
to a heterologous carrier. After washing, the specific proteins were usually eluted with 
2.5 M NaSCN and dialyzed against borate-buffered saline or phosphate-buffered saline. 
In some cases, the bound antibodies were eluted with step gradients of NaSCN beginning 
with 0.16 M and increasing the concentration by twofold increments until all the bound 
protein was eluted. 
Preparation ofAD8 F(ab')2 Fragments.  F(ab')~ fragments of ADS were isolated from a 
Staphylococcus aureus V8 proteinase (No. 39-900; Miles Laboratories) digest by stepwise 
elution  from  DE-52  (Whatman  Ltd.,  Kent,  England)  according to the  procedures of 
Rousseaux  et  al.  (20).  The  products  were  characterized by sodium  dodecyl sulfate- 
polyacrylamide gel electrophoresis and by inhibition of AD8-biotin-binding activity in an 
enzyme-linked immunosorbent assay (ELISA). 
Idiotope and Antibody Assays.  Idiotope, isotype, and specific antibody titers were deter- 
mined with ELISA (11).  In our standard inhibition idiotope assay, we coated microtiter 
plates with a solution of the CRI  ^Ds+ protein R16.7 at 2 #g/ml. Binding of AD8, AD8- 
biotin, or 5Ci-biotin (200-300 ng/ml) to the R16.7 plate was inhibited by serial dilutions 
of the test protein or sera.  We measured the amount of antiidiotope bound with goat 
anti-rat Ig-alkaline phosphatase or avidin-alkaline phosphatase.  Idiotope titers are ex- 
pressed either as  protein concentration or  serum  dilution that  inhibits  50%  maximal 
binding. Bound alkaline phosphatase was usually revealed with the chromogenic substrate 
p-nitrophenyl phosphate (NPP) (No. N-3254; Sigma Chemical Co.).  In some assays,  we 
increased the sensitivity of the system by using the fluorogenic substrate 4-methylumbel- 
liferyl phosphate (4-MUP) (No. M-8883; Sigma Chemical Co.), reducing the concentration 
of antiidiotope as indicated and reading the fluorescence on a microtiter plate fluorometer 
(No. 100-100; AIlergenetics, Mountain View, CA). 
Isotypes  were  determined  by  incubating  antibody  dilutions  on  plates  coated  with 
antigens (10 #g/ml) or AD8 F(ab')2 (3 ~g/ml) for 4-18 h. The isotypes of bound antibodies 
were determined with either rabbit anti-~  or anti-M  alkaline phosphatase-monoclonal 
antibody (mAb) conjugates. 
Antigen  specificities were assayed by incubating antibody dilutions on plates coated 
with antigens or haptenated proteins at 10 ~g/ml, including ABA-BSA, ABP-BSA, TNP- 
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phosphatase. In some cases, the antibody dilutions were set to allow measurement of the 
concentrations of antibody at half saturation. 
Hybridomas and Hybridoma Proteins.  We developed two protocols for enhancing hy- 
bridoma production, both of which yielded 5-10-fold more hybrids than did conventional 
recipes. The first procedure relied on a  method, described by Haas (21), for enriching 
TNP-specific B cells from A/J mice primed with  TNP-conjugated AD8.  Donor spleen 
cells were incubated at 4°C on plates coated with TNP-gelatin. After removal of nonad- 
herent cells, adherent cells were released by melting the gelatin at 37 °C. After washing, 
we treated the cells with coilagenase, cultured them for 6 d with lipopolysaccharide and 
rat thymocyte feeders (22), and fused the cells with SP2/0  cells,  as described (23).  We 
used ELISA to screen hybridomas for coexpression of CRI  ^D82 and TNP-binding activity. 
One stable, anti-TNP, CRI  ^DS+ hybridoma, TL1-NS, was isolated using the first proce- 
dure, and is characterized in Results. In the second procedure, we injected mice with 50 
ug TNP-CGG in  0.05  ml CFA once in each hind footpad.  10  d  later, popliteal lymph 
node cells were harvested, fused with SP2/0 cells (23), and seeded at 6  ×  104 precursor 
lymph node cells/well in 96-well microtiter plates. Peritoneal cells were added as feeders 
(~4  ×  l0 s cells/well). We isolated six stable, anti-TNP, CRI  ADS+ hybridomas, identified 
by the prefix TCP, using the second procedure. These are characterized in Results. 
In addition to the new hybridomas of the TLI and TCP series described in this paper, 
we have relied on many previously described hybridoma proteins. The rat antiidiotope 
mAb AD8 and 5Ci  were prepared as described (11,  24).  5H5,  2E2, and  1F6 are anti- 
antiidiotope members of the CRI  ADS family: 5H5 and 2E2 were derived from A]J mice 
immunized with AD8 (11), and  1F6 from mice immunized with 5Ci (24).  5Ci and  1F6 
were from L.  Wysocki (24).  AB2-24.1,  AB2-37.2,  and AB2-143.2 are arsonate-specific 
members of the CRI  ^D8 family and were derived from A]J mice immunized with ABA- 
brucella (11). The sequenced ABA  + proteins 93G7,  123E6,  124E1, and 91A3 were from 
J.  D.  Capra (13,  25).  The ABA + hydridomas 36-65,  31-62,  16-46-6, and 45-223  were 
from A. Marshak-Rothstein (26).  The ABA  ÷ protein R16.7 was from E. Lamoyi and A. 
Nisonoff (27), while the protein L22.18.2, an antimurine ),1 reagent, was from R. Epstein 
(28). 
Hybridomas were grown either in culture or as ascites (1 l).  We isolated hybridoma 
proteins  of defined  specificities  on  the  appropriate  immunoadsorbent  matrices,  and 
desorbed them with NaSCN. For instance, 36-65 and AB2-24.1  were isolated on ABA- 
BSA columns, while TL1-N5 and TCP-2A2 were isolated on TNP-BSA columns. Anti- 
bodies with unknown specificities, like 5H5 and 2E2, were grown in serum-free medium 
and isolated on protein A-Sepharose (11).  We grew AD8 and 5Ci as ascites in nude mice 
and isolated them on DE-52, as described (11). 
Results 
CRI  aDS+ Antibodies  Are Differentially  Elicited by Various Epitopes.  In a  previous 
report  (11),  we  described  CRI  ADS  among  naturally  occurring  antibodies,  but 
were  unable  to  determine  their  specificity.  The  possibilities,  then,  were  that 
CRI  ADS  is  used  by  antibodies  of many  different  specificities,  as  reported  for 
certain Vn markers in rabbits (29) and mice (30, 31); or, that it is found only on 
anti-ABA  antibodies  and  naturally  occurring antibodies  of a  single  specificity. 
To  clarify  this  point,  affinity-purified  antibodies  from  several  antihapten  re- 
sponses were examined for CRI  AD8 content. Six groups of mice were immunized 
with CGG or CGG conjugated  with one of five different haptens:  ABA,  TNP, 
DANS,  FL,  or  ABP.  Among  these  ABA  and  ABP  are  of particular  interest 
because  they  have  similar  structures  and  are  known  to  elicit  cross-reactive 
antibodies in rabbits (32).  Antibodies to each hapten and to CGG were affinity 
purified and analyzed for CRI  AD8 content. 
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FIGURE  1.  CRI  ADs content of representative affinity-purified antibodies of different specific- 
ities. CRI ^°s was measured with an ELISA, in which the binding  of AD8 (50 ng/ml) to R16.7- 
coated plates was inhibited by serial twofold antibody dilutions. Bound AD8 was assayed with 
anti-rat Ig-alkaline phosphatase  conjugates  followed by the fluorogenic  substrate  4-MUP. 
Percent maximum fluorescence  is plotted on the abscissa, versus inhibitor concentration on 
the ordinate. Inhibitions,  done in triplicate, were averaged; error bars span +1 SD. Inhibitors 
were: 36-65 (O), anti-ABA (I), anti-CGG (A), anti-TNP (A), anti-ABP (V), and anti-DANS (T). 
TABLE  I 
CRI  ans Levels in Antibodies of Various Specificities 
CRI ^Ds titer* at 50%  Percent antibody 
Antibody*  inhibition  CR|  ^Ds÷ 
pg/ml 
36-65  0.0054  100 
Anti-ABA  0.012  47 
Anti-CGG  0.38  1.4 
Anti-TN  P  0.51  1.1 
normal IgG  1.2  0.43 
Anti-FL  74  0.007 
Anti-DANS  76  0.007 
Anti-ABP  81  0.007 
* Specific antibodies were affinity purified from pooled antisera to ABA- 
CGG, CGG, TNP-CGG, FL-CGG, DANS-CGG, and ABP-CGG. Hybri- 
doma protein 36-65 (26) was affinity purified from ascites fluid. Normal 
A/J IgG was isolated from CFA-induced ascites as described (11). 
* CRI A•s  titers are expressed as the antibody concentration which inhibits 
50%  of the  binding of AD8  to  R16.7-coated  plates  in an enhanced 
ELISA. AD8 concentration was reduced from 200 ng/ml to 50 ng/ml 
and the amount of AD8 bound was measured with a goat anti-rat lg- 
alkaline phosphatase conjugate followed by the fluorogenic substrate 4- 
MUP. 
specificities varied over five orders of magnitude. Included for comparison is the 
standard hybridoma protein 36-65, which is strongly CRI  A°s+ and binds ABA. 
Significantly, the slopes of inhibition for all the antibody populations shown in 
Fig.  1  are  equivalent,  suggesting  that  the  CRI  Aos  moieties  in  each  antibody 
population  bind  to  AD8  with  similar  affinities.  This  reinforces  our  earlier 
conclusion  (1 1)  that  CRI  ADs,  though  intimately associated  with  the  antigen- 
binding structure,  is not identical to  it.  This equivalence of slopes allowed an 58  IDIOTYPIC  DOMINANCE  IN  THE  ANTIARSONATE  RESPONSE 
estimate of the percentage of each antibody population containing CRI TM, which 
we have summarized in Table I. The antibodies can be divided into three groups. 
The group expressing the highest proportion  of CRI  A°8 includes hp 36-65, all 
of which  is assumed  to express the  idiotope,  and  anti-ABA  serum  antibodies, 
47% of which contain CRI ADS. The group expressing intermediate idiotope levels 
(Table  I, rows 3-5)  includes normal  A/J IgG as well as antibodies specific for 
CGG and  TNP, which contain  0.4,  1.4, and  1.1%  CRI  A°8+ antibodies,  respec- 
tively.  Surprisingly,  antibodies  to  ABP  contained  only  traces  of CRI  A°8  and, 
along  with  antibodies  to  FL and  DANS,  comprised  the  group  expressing  the 
lowest levels of idiotope. Only -0.007% of these antibodies express CRI  An8, and 
possibly even  this  is  due  to  nonspecific  copurification  of naturally  occurring 
CRI  ^~)8 along with specific antibodies; the vanishingly small amounts of CRI AD8 
in these preparations precluded further characterization. 
The ability of both CGG and TNP to elicit CRI  A°8 was confirmed in a number 
of subsequent experiments.  First, the possibility that CRI  ADs expression by anti- 
TNP antibodies is carrier dependent was ruled out by the experiment shown in 
Table  II.  We  immunized  mice  with  either  TNP-RGG  or  RGG  in  CFA,  bled 
them 7 d  later, and analyzed the antisera  for idiotope content.  CRI A°8 levels in 
the antisera to the TNP-carrier conjugate were 12-fold higher than in the antisera 
to the carrier alone (groups A and B, Table II), indicating that the ability of TNP 
compounds  to  enlist  CRI  ADs+ antibodies  is  carrier  independent.  Second,  two 
batches of CGG, independently prepared, consistently elicited CRI  AD8+ antibod- 
ies (data not shown). Third, the possibility that CGG enlisted CRI  ADs+ responses 
because it  was contaminated  with  arsonate  was directly  ruled  out by graphite 
furnace, atomic absorption spectrophotometry; no arsenic was detected in either 
batch of CGG (data not shown). 
CRI  aos Dominance of Antibodies  to TNP Cannot Be Elicited by Immunization With 
TNP-ABA-KLH.  As shown above, CRI  ADs is a dominant idiotope in the response 
to ABA but a minor idiotope in the response to TNP. We attempted to increase 
its expression  in  the  anti-TNP  response  by immunizing  mice  with  the  doubly 
haptenated  immunogen  TNP-ABA-KLH. We postulated that  TNP-ABA-KLH 
might  increase  the  CRI  A°8 representation  in  the  anti-TNP  component of the 
response, based on two sets of observations. First, antibodies to different deter- 
minants on the same protein antigen can share a common cross-reactive idiotype 
TABLE  II 
Influence of Immunizing With TNP on Serum CRI  a°8 Levels 
Group  n  Immunogen*  CRI ^n8 titer  x 
A  6  RGG  34 (2.19) 
B  6  TNP-RGG  4t7 (1.99) 
*  Mice were  immunized with  0.1  mg immunogen in  CFA  and bled  7  d 
later. 
* CRI ADS titers are expressed as serum dilutions that inhibit 50%  of the 
binding  of  200  ng/ml  AD8  to  R16.7-coated  plates  in  our  standard 
ELISA. The amount of bound AD8 was quantitated with a goat anti-rat 
1G-alkaline  phosphatase conjugate  followed  by  the chromogenic  sub- 
strate  NPP.  Values  are  expressed  as  the  geometric  means,  with  the 
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(33-37), suggesting that different epitopes on the same immunogen can selectively 
call up idiotypically related antibodies. Second, idiotype-specific T  helper cells, 
which have been reported in the CRI  a system (5), would, presumably, be enlisted 
in response to TNP-ABA-KLH. If helper cells specific for the CRI  ADs VH region 
are responsible  for the dominance of the anti-ABA response by CRI  ADs, then 
they might also provide help to CRI  ADS+, TNP ÷ clones. To test this possibility, 
A/J mice were hyperimmunized with either TNP-ABA-KLH or TNP-KLH. We 
then  isolated  anti-TNP  or  anti-ABA  antibodies  from  pooled  ascites  fluid  by 
affinity chromatography  on  a  TNP-OVA-Sepharose  immunoadsorbent.  The 
anti-TNP  antibodies  were  then  depleted  of possible  contaminating anti-ABA 
activity by  passage  through  ABA-tyrosine-Affi-gel columns  and  analyzed for 
CRI  ^'8.  As  shown  in  Table  III,  anti-ABA  antibodies  contain  24  times  more 
CRI  A°8 than anti-TNP antibodies (row  I  vs. rows 2  and 3).  Significantly, anti- 
TNP  antibodies isolated from TNP-ABA-KLH-immune mice did not contain 
elevated  levels  of CRI  ^Ds  relative  to  anti-TNP  antibodies  from  TNP-KLH- 
immune mice (Table  III, row 2  vs.  3).  This result suggests that if antiidiotypic 
helper cells are responsible for the dominance of CRI  ADs in the ABA response, 
they are  incapable  of helping  clones  expressing  CRI  ADs  on  immunoglobulin 
specific for TNP. Regardless of the mechanism of idiotope dominance, it is clear 
that CRI  ADS alone is not sufficient to establish it. 
Relationship of Phosphonate-binding Site and CRI  ao8 Use.  The possibility that 
the phosphonate and arsonate groups elicit cross-reactive antibodies with over- 
lapping  specificities  but  dissimilar  idiotopes  (Table  I)  provides  a  particularly 
appealing system to examine idiotope use in the antigen-driven selection of the 
expressed  repertoire.  For  example,  although  5-40%  of the  antibodies  raised 
against ABP cross-reacted with ABA (data not shown), they expressed only traces 
of CRI  ADs (Table  I).  This result implies that clones responding to ABP,  even 
those  which  bind  ABA,  effectively lack  CRI  At)s. This  might be  explained  by 
inferring that structural  constraints prevent  ABP-binding antibodies  from ex- 
pressing  CRI  ADs  or  that  regulatory  constraints  limit  the  expansion  of ABP- 
binding clones which also express this idiotope. These possibilities were explored, 
first, by determining if ABP-cross-reactive  antibodies isolated from anti-ABA 
TABLE  III 
Effect of ABA on CRI  aos Levels in Antibody Response to TNP 
CRI  ADs titer  ~  at 50% 
Antibodies*  Immunogen  inhibition 
t~g/ml 
Anti-ABA  TNP-ABA-KLH  0.6 
Anti-TNP  TNP-ABA-KLH  14.3 
Anti-TNP  TNP-KLH  12.2 
*  Anti-TNP antibodies were affinity purified on TNP-OVA-Sepharose 
and depleted of possible anti-ABA contamination by passage over ABA- 
tyr-Affigel. 
* CRI  ^t)s levels  are expressed as the antibody concentration which inhibits 
50% of the binding of 200 ng/ml AD8 to R16.7 plates in the standard 
ELISA using the NPP substrate. Data from three separate assays were 
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serum express CRI  ADs, and  second,  by determining  if CRI  A°s+ anti-ABA  mAb 
also bind ABP. 
That CRI  AD8+ antibodies can bind ABP was demonstrated in both serum and 
hybridoma  antibodies.  We  separated  serum  anti-ABA  antibodies  (from  anti- 
ABA-KLH ascites fluid) into ABP-cross-reactive and non-cross-reactive fractions 
using an  ABP-BSA  immunoadsorbent,  and  analyzed  them  for  CRI  ADs  (Table 
IV).  ABP-cross-reactive  antibodies  raised  against  ABA  contained  4%  of  the 
CRI  ADs found in antibodies specific for ABA alone (compare rows 1 and 2, Table 
IV). In contrast, anti-ABP antibodies raised against ABP contained ~0.015%  of 
the  CRI  ADS  in  anti-ABA  antibodies  (rows  8  and  2,  Table  I).  Thus,  anti-ABP 
antibodies  raised in  response to ABA expressed CRI  ^Ds at least  300-fold more 
effectively than  those raised  in response to ABP.  Since the  slopes of inhibition 
of the ABP-cross-reactive antibodies were the same as for anti-ABA antibodies 
(data not shown), we suspect that the reduced level of idiotope observed for the 
ABP-reactive  antibodies  reflects  a  lower  content  of  CRI  AD8,  rather  than  an 
alteration  of the  idiotope  structure.  In  either  case,  however,  this  result  shows 
that serum antibodies which express CRI  AD8 can also bind ABP.  One objection 
to this conclusion  is the possibility that some CRI  ADs+ antibodies nonspecifically 
adsorbed  to  the  ABP-BSA  columns.  To  circumvent  this  criticism,  mAb  were 
examined for the expression of CRI  ADs and the ability to bind phosphonate. 
Anti-ABA hybridoma proteins were compared for their expression of CRI  ADs 
and their abilities to bind ABP and ABA. Hapten-binding activity was measured 
with ELISA in which serial dilutions of antibodies were reacted with ABP-BSA- 
or ABA-BSA-coated plates. Antibody concentrations at 50% maximum binding 
were  determined,  when  possible.  As  shown  in  Table  V,  there  is  no  apparent 
correlation between CRI  AD8 and the relative ability to bind ABP or ABA. In the 
group  of  molecules  that  express  CRI  ADs  best,  16-46-6  binds  ABP  twice  as 
effectively as ABA, AB2-24.1  binds ABP nearly as strongly as ABA, while 36-65 
and  AB2-143.2  bind  ABP  at  least  8-  and  44-fold  less  effectively  than  ABA, 
respectively. Similarly, no trend is seen among CRI  ADs- antibodies:  31-62 binds 
phosphonate  twice as effectively as arsonate,  while  123E6,  124E1,  and  45-223 
TABLE IV 
CRI arts Expression in the Anti-ABA Response: A Comparison of 
ABP-cross-reaetive  and Non-cross-reactive Antibodies 
CRI  ^Ds titer ~ at 
Antibodies*  Protocol  50% inhibition 
#g/ml 
Anti-ABA  Depleted of anti-ABP  0.09 
Anti-ABP  Desorbed with 0.16 M NaSCN  2.10 
Antibodies to ABA were isolated from anti-ABA-KLH ascites fluid on 
an ABA-BSA column. These antibodies were subsequently fractionated 
into  ABP-cross-reactive  and  non-cross-reactive  portions  by affinity 
chromatography  on an ABP-BSA immunabsorbeot.  Anti-ABP antibod- 
ies were desorbed  from the column using 0.16  M NaSCN in borate- 
buffered saline. 
Idiotope titers are expressed as the antibody concentration which inhibits 
50% of the maximum  binding  of AD8 to R16.7-coated  plates in an 
enhanced ELISA (as described in Table I). HORNBECK  AND  LEWIS  61 
TABLZ V 
Comparison of Ability of CRl  a°~+ and CRI  ads-, Arsonate-specific raAb to Bind Phosphonate 
Antibody concentration (X 10-S/ml) 
at 50% maximum binding to plates 
mAb  coated with:*  ABP/ABA ratio  CRI ^Ds* 
ABA  ABP 
16-46-6  4.8  2.3  2.1  ++ 
AB2-24.1  2.2  2.8  0.78  ++ 
36-65  1.9  > 16  d0.12  ++ 
AB2-143.2  5.2  >231  <0.02  ++ 
AB2-37.2  5.6  7.5  0.75  + 
R16.7  1.3  >8.1  <0.16  + 
93G7  1.9  >6.2  <0.31  + 
31-62  1.2  0.56  2.1  - 
91A3  2.2  >10  <0.22  - 
123E6  0.81  >6.2  d0.13  -- 
124E1  1.6  >125  <0.01  - 
45-223  1.6  >625  <0.003  - 
* Specific antibody titers were measured with ELISA in which dilutions of mAb were incubated on 
plates coated  with  either  ABA-BSA or  ABP-BSA.  Bound antibody was assayed with  rabbit anti- 
mouse-alkaline phosphatase conjugates.  Antibody  molarity at  50%  maximal binding was deter- 
mined in those cases where saturation binding was achieved. 
* CRI ^D8 expression, assessed in our standard inhibition ELISA, was scored relative to 36-65, which 
was assigned a  value of 100%, as follows:  10-170% (++);  1-10% (+); and not detected (-). 
all  bind  phosphonate  less  effectively than  arsonate.  These  results  show  that 
CRI  ADs÷ antibodies can bind ABP, and that some even bind ABP more effectively 
than  ABA.  Furthermore,  CRI  ADs- antibodies bind  ABP no better than  ABA. 
Thus, it is difficult to explain why immunization with ABP fails to elicit CRI  ^D8. 
It might be argued that CRI  ^Ds+ clonal precursors bind ABP relatively weakly, 
and that affinity selection in anti-ABP responses preferentially expands CRI  ADs- 
clones. However, since antigen  is not limiting,  this possibility appears unlikely. 
Apparently, the differential abilities of ABP and ABA to expand CRI  ADs+ clones 
cannot be explained simply by the capacity of B cell antigen  receptors to bind 
antigen.  This  result  is consistent with the existence of an auxiliary mechanism 
that preferentially expands CRI  ^Ds+ clones in the response to ABA but not ABP. 
In the Discussion, the possibility is raised that  ABA itself is an auxiliary factor 
required to establish dominance. 
Production  of TNP ÷, CRI A°8+ Hybridomas.  While  the above results  strongly 
suggest  the  existence  of TNP  ÷,  CRI  A°s+ antibodies,  proof Of their  existence 
requires mAb with this phenotype. To this end, two protocols were developed 
that  increased  the  frequency of anti-TNP  hybrids.  The  first procedure,  using 
LPS-stimulated, TNP-specific spleen cells, yielded one stable CRI  Ans÷ hybridoma 
out  of  110  TNP ÷ clones (TL1-N5,  Table  VI).  The  second  procedure,  using 
popliteal  lymph  node cells from  mice  immunized  10  d  previously with  TNP- 
CGG,  yielded  six  stable  CRI  ADs+ hybridomas  out  of 237  TNP ÷  wells  (TCP 
proteins, Table VI). 
As shown in Table VI, all heavy chain isotypes except IgD and IgA were found 
on TNP ÷, CRI  Ao8+ hybridomas.  Interestingly,  two out of seven of these use ),1 
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TABLE  VI 
lsotypes of Hybridoma Proteins  Which Express CRI  a°s and Are 
Specific  for TNP 
Protein 
Isotype 
Heavy chain  Light chain 
TL1-N5  lgM  hl 
TCP-2C3  lgG3  X  1 
TCP-2A3  IgG1  K 
TCP-2B2  lgG2b  x 
TCP-1 B3, -2A 1, -2A2  lgG2a  s 
lsotypes were determined using ELISA in which hybridoma supernatants 
were  incubated  on  plates coated  with AD8-F(ab')~.  The  isotypes of the 
bound antibodies were determined with antiisotype-alkaline phosphatase 
probes.  Antigen  specificity  was determined  by  depletion  of CRI ^Ds on 
TNP-BSA immunoabsorbents. 
TABLE  VII 
Comparison of Light Chain Isotypes  Used by mAb Against Either TNP 
or CGG 
Total number of 
Antigen  hybridomas  Percent ~.1  Percent K 
CGG  168  3  97 
TNP  110  23  77 
Hybridomas to TN P and CGG were prepared from popliteal lymph nodes 
of mice immunized once with TNP-CGG and fused with SP2/0 cells. Light 
chain  isotypes  were  determined  with  EL1SA.  Plates  were  coated  with 
either  TNP-BSA  or  CGG,  reacted  with  hybridoma  supernatants,  and 
developed  with  anti-M  mAb  or  polyclonal  anti-x-alkaline  phosphatase 
conjugates. 
light chains (11 ). The use of X  1 light chains on antibodies specific for TNP might 
be  explained  by  the ability  of X1  light chains  to bind  nitrophenyl  groups (38, 
39).  To determine if X1  is used preferentially  by anti-TNP hybridoma proteins 
in  this  system,  X1  expression  by  anti-TNP  antibodies  was  compared  to  X1 
expression among anti-CGG  antibodies  isolated  from the same fusion.  As seen 
in  Table  VII,  23%  of the anti-TNP  antibodies  used  M,  while  only  3%  of the 
anti-CGG  antibodies did so.  Thus,  in this system,  the  use of X1  by two out of 
seven TNP +,  CRI ADs+ hybridoma proteins is proportional to its use by all anti- 
TNP hybridomas. 
The  efficiency  of CRI ADs expression  by  anti-TNP  hybridoma  proteins  was 
explored  in  more detail  by comparing its expression  on  three affinity-purified 
TNP +, CRI AnS+ proteins with the canonical CRI ADs+, anti-ABA protein  36-65. 
We included 91A3 as a negative control.  ELISA inhibition curves (Fig. 2) show 
that  all  three  anti-TNP  proteins  express  CRI  ADs as  effectively  (TCP-2C3),  or 
nearly as effectively (TL1-N5 and TCP-2A2), as 36-65. It is noteworthy that the 
expression of CRI ADs can be similar in antibodies using either X1 (TCP-2C3) or 
x (36-65) chains (also see Table VIII). In summary, hybridoma production proves 
that CRI ADs can  be  expressed  on  anti-TNP  antibodies  as well as on anti-ABA 
antibodies, and that its expression is largely determined by the heavy chain. HORNBECK  AND  LEWIS  63 
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FIGURE 2.  CRI ^Ds expression  by three anti-TNP hybridoma proteins compared  with anti- 
ABA hybridoma 36-65. The anti-ABA hybridoma protein 91A3 was included as a negative 
control. Anti-TNP antibodies were  affinity  purified on TNP-BSA  immunoabsorbents and 
chaotropically  eluted. CR1 ^D8 was measured with an ELISA, in which the binding of AD8- 
biotin (200 ng/ml) to R 16.7-coated plates was inhibited  by dilutions  of the five proteins. Bound 
AD8-biotin was assayed with avidin-alkaline  phosphatase conjugates followed by the chrom~ 
genie substrate  NPP.  Inhibitors were: 36-65 (O), TCP-2C3 (O), TL1-N5 (A), TCP-2A2 (A), 
and 91 A3 IV). 
TABLE VIII 
Light Chain, J,, and I1, Usage Compared With CRI  aDS Expression 
CRI ^D~ (t~g/ml 
Hybridoma  Light  Ju  Vn CRI  ~  at 50% 
protein  chain*  inhibition 
36-55  V,-~0  2  +  0.07 
2 E2  V,-o  2  +  0.10 
AB2-143.2  V~-~  3  +  0.04 
5H5  V~-~  4  +  0.06 
TCP-2C3  Vxl  ?  ?  0.13 
TL1-N5  Vxl  ?  ?  0.30 
* VL subgroups and isotypes were determined either from the amino acid 
sequences or serologically. The sequence of 36-65 was reported previ- 
ously (54, 55), and that of the 48 N-terminal residues of 2E2 has recently 
been determined by M. Margolies. All other isotypes were determined 
by ELISA. 
*J, and Vu CRI ~ usage was determined by L. Wysocki (personal commu- 
nication) as described (12). Briefly, DNA from various hybridomas was 
digested  with EcoRI, electrophoresed  in agarose,  transferred to nitro- 
cellulose paper,  and hybridized  with a  labeled  V~ CRI a probe as de- 
scribed (12). 
a CRI ADS content is expressed as the antibody concentration which inhibits 
50%  of the maximum binding of AD8  to  R16.7-coated  plates  in an 
ELISA (as described in Table III). 
CRI  a°8 Correlates With the CRI  a VI~ Region, Exclusive of  JH.  We have suggested, 
here and elsewhere (1 1), that CRI  A°~ depends upon VH regions that contain the 
germline CRI"  VH  segment (12).  Additionally, the  expression of CRI  ADS  may 
depend  upon  a  particular  D  segment gene  that  is  characteristic  of CRI  a+  Vn 
regions (13).  Six arguments support mapping CRI  ADS to the VH region: (a) The 
expression of CRI,  ADS is linked to the A  strain Igh locus (1 1), which contains both 
VH CRI" and the D  segment alleles. (b) All CRI  a°8+ hybridomas that have been 64  ID1OTYPIC  DOMINANCE  IN  THE  ANTIARSONATE  RESPONSE 
examined at  the DNA level have undergone rearrangements of the VH  CRI  a 
gene (L.  Wysocki, personal  communication). For  example, as  summarized in 
Table VIII, restriction mapping and hybridization with a labeled VH CRI  a probe 
showed that  all  four of the  CRI  ADs+ hybridomas examined have  undergone 
genomic rearrangements of the VH CRI  a gene. (c) CRI  ADs expression, like that 
of CRI  a (40, 41), is independent of a particular JH segment. As summarized in 
Table VIII, proteins 36-65 and 2E2 useJn2; AB2-143.2 uses JR3; and 5H5 uses 
J,4 (L. Wysocki, personal communication). The CRI ADs titers of all four proteins 
are very similar, ranging from 0.04 ug/ml for AB2-143.2 to 0.10 ug/ml for 2E2. 
The independence of CRI  ADs and JH might be explained by the largely internal 
location of Jn (42), which suggests that this region does not directly contribute 
to the idiotopic surface structure. (d) CRI  ADs is expressed on antibodies with 
different light chains. As shown in Table VIII, proteins that have V~-,0, VK-~, or 
X1 all effectively express CRI  ADs. (e) CRI  ADs is expressed by isolated heavy chains 
(11,  43).  (f) CRI ADs correlates with the sequence encoding 36-65,  which ex- 
presses the germline-encoded CRI  ~ VH sequence and a  distinctive D  segment 
(13), and is successively lost in proteins known to diverge from this sequence. To 
illustrate this,  the number of amino acid substitutions,  in both the VH and  D 
segments of nine  idiotypically related  hybridoma proteins,  relative  to  36-65 
sequences, is compared with CRI ADs expression (Table IX). CRI ~ci expression is 
included as a  control. Seven of the VH regions shown in Table IX have been 
sequenced entirely (12,  13,  25, 41,  54) and another (2E2) has been sequenced 
through 51 of the first 52 amino-terminal residues (M. N. Margolies, unpublished 
observations). CRI  ADs correlates with the VH and D sequences of protein 36-65, 
while the control idiotope CRI 5c~ shows no such correlation. For instance, protein 
2E2, which is identical to 36-65 in the region that has been sequenced, expresses 
TABLE  IX 
CRI  ans Is Most Strongly Expressed on the CRI  a Prototype Protein and Is Lost Upon Divergence 
From the Prototype 
Amino acid substitutions* 
Hybridoma*  CRI  ^nsg titer  CRI scil titer 
V.  D 
36-65 (54)  0  0  1  1 
2E2 (56)  0  ?  1.3  >10,000 
93G7 (13)  3  1  12  42 
R16.7 (13)  4  1  11  6 
1  F6 (40)  9  2  71  3 
123E6 (25)  7  1, and 1 insertion  >10,000  8 
124E1  (13)  8  2  >10,000  1 
91A3 (13)  10  2, and 1 deletion  >10,000  >10,000 
* Sequences of V. regions were determined as described in the references in parentheses. All  V. 
sequences are complete except 2E2,  which has been sequenced through  51  of the first 52  N- 
terminal residues. 
* Substitutions in the V. segment (residues  1-94) are relative to  36-65,  which is the unmutated 
product of the V.  CRI  a gene (12,  54).  The  D  segments (residues 95-100),  with substitutions 
relative to 36-65, also have an amino acid insertion (123E6) and a deletion (91A3). 
ldiotope content is expressed as the relative amount of protein which inhibits 50% of the binding 
of either AD8-biotin or 5Ci-biotin to R16.7-coated plates in our standard ELISA. The units are 
arbitrary and adjusted so that the CRI  Aas titer of protein 36-65 is 1.0. HORNBECK  AND  LEWIS  65 
CRI  ADs with  about the same efficiency as  36-65,  but does not express CRI  5c~ 
Protein  1F6, which contains nine  VH and two D  segment substitutions relative 
to  36-65,  expresses  CRI  ADs  70-fold  less effectively than  36-65,  but  expresses 
CRI  5ci with about the same efficiency as 36-65.  In contrast,  124E1, which has 
eight VH and two D segment amino acid differences compared with 36-65, has 
lost  CRI  ADs  but  expresses  CRI  ~ci  as  strongly  as  36-65  does.  Thus,  CRI  ADs 
correlates  with  both  the  CRI  ~ VH  segment  and  the  36-65  D  segment,  and  is 
independent of the light chain or JH. 
While the precise location of CRI  ADs is unknown,  the ability of both hapten 
and antigen  to inhibit  the binding of AD8 to CRI  ADs+ antibodies suggests that 
the  idiotope  resides  in  the  hypervariable  region  of the  molecule  (56).  This 
assumption, in concert with available Ig structural  data, and the possibility that 
the  majority  of amino  acid substitutions  in  functional  proteins have  predomi- 
nantly  local effects (44),  allowed us to postulate that  CRI  ADs is determined  by 
CDR-2 or the D segment (unpublished observations). This provisional assignation 
awaits further structural  data for verification.  It will be particularly interesting 
to study the complete structures  of the TNP  + members of the CRI  ADs family, 
which  should  reveal  the  relative  contributions  of VH  and  D  regions  to  the 
idiotope, as well as increase our understanding  of how the same VH structures 
can be used to construct antibodies of different specificities. 
Discussion 
The  main  finding  of this  report,  that  CRI  ADS  dominates  some  antihapten 
responses but not others, shows that the CRI  ADs VH region is necessary but not 
sufficient for idiotype dominance,  and  suggests that  an additional  specificity is 
involved.  This  suggestion  introduces  a  new  constraint  on  the  mechanism  of 
idiotype dominance, with the caveat that these conclusions may be limited to the 
A strain anti-ABA response, because no single mechanism currently accounts for 
all observations made in all systems. 
For example,  in  the T 15  system, idiotype dominance  can be traced back to 
the  pre-B  cell  stage  where  most of the  surface  Ig-  precursors  (whiCh,  in  the 
splenic focus assay, differentiate in response to phosphorylcholine; PC) are T 15 + 
(3, 45). While these findings do not exclude a role for idiotype-specific helper T 
cells, it is not necessary to invoke them  to explain  idiotype dominance  in this 
system. On the other hand,  the situation is different in the CRI  a system, where 
only 3% of the nonimmune,  arsonate-specific B cells responding in the splenic 
focus assay are CRI  a÷ (4). This frequency increases 7-30-fold after immunization 
with T-dependent conjugates, suggesting that the precursors bearing this idiotype 
are selectively expanded. This expansion might be explained by either idiotype- 
specific helper cells or preferential  suppression of idiotype-negative precursors. 
In the latter, suppression could be mediated by antiidiotypic suppressor T  or B 
cells. 
Our data strongly suggest that CRI  Ao8 is expressed by CRI  ~ VH regions, and 
thus provides a  marker  for analyzing  CRI  ~ dominance  in anti-ABA  responses, 
This assumption is based on the observations that CRI  ^°s has been found only 
on CRP VH regions, and that the CRI  A°s+ subset, like the rest of the CRI  a family, 
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been tested by precursor analysis; however, it is supported by two other obser- 
vations. First, CRI An8 is not as dominant in T-independent anti-ABA responses 
as  it  is  in  T-dependent responses  (46),  arguing that  CRI  A°8-  precursors are 
relatively frequent in nonimmune mice. By contrast, in the T15 system, both T- 
dependent and T-independent responses are dominated by T15 (3, 47). Second, 
idiotype suppression experiments argue that CRI  A°8 is a smaller fraction of the 
ABA-specific precursor pool than T15  is of the PC-specific precursor pool. In 
cRIADS-suppressed  mice,  anti-ABA  responses  are  normal  even  shortly  after 
suppression (unpublished observations), suggesting that CRI  ADS- precursors read- 
ily compensate for the deleted clones. This result would be predicted if only 3% 
of the ABA-specific precursor pool was CRI ADS+. On the other hand, in T15- 
suppressed mice, anti-PC  responses are lost  for several months after idiotype 
suppression (48, 49), suggesting that the majority of PC precursors are T 15 + (3, 
45). Taken together, these two observations are most consistent with dominance 
in  the CRI A°8 system being due to selective expansion of CRI ADS+ precursors 
after immunization with ABA. 
If this  expansion  is  mediated by an antiidiotypic helper ceil,  two  questions 
arise. First, what additional specificity, expressed by CRI A°8+ anti-ABA antibod- 
ies, does the helper recognize? And, second, why is there more help for CRI  ADS+ 
anti-ABA clones than for those lacking this idiotope? 
There are at least five candidates for the additional specificity recognized by 
an antiidiotypic T  helper cell: the light chain V and J  segments; the heavy chain 
D andJ segments; and ABA itself. Helper cells that recognize light chain idiotopes 
have been reported (50), and it is possible to explain the lack of recognition of 
the TNP- and CGG-specific members simply by postulating that the helpers only 
recognize the light chain V, regions used by the ABA-specific members. The 
anti-ABP response argues differently. Immunization with this hapten does not 
call up any significant CRI ADS+ antibody, even though immunization with the 
ABA group calls up ABP cross-reactive antibodies expressing CRI  ADS. Similarly, 
anti-ABA hybridoma proteins that express CRI  ^D8 also bind ABP. If the idiotype- 
specific T  helpers are simply recognizing V~ determinants, then immunization 
with  ABP  (like  immunization  with  ABA)  should  call  up  significant  levels  of 
CRI ADs, which in fact, it does not. 
The hypothesis most consistent with the above data is that a complex between 
ABA and the CRI ADs+ VH region is recognized by the helper cell. This would 
explain the lack of dominance in the anti-TNP and -CGG responses, as well as 
the absence of CRI ADs in anti-ABP cross-reactive responses.  In the latter,  im- 
munization with ABP would not call up CRI ADs÷ antibodies because ABP would 
not cross-react with ABA at the T  cell level (51). Additionally, the requirement 
for ABA in this regulatory circuit accounts for observations, in both the CRI  ~ 
(24) and CRI ADs (11) systems, that CRI  + ABA- components are not expanded in 
antibody responses to ABA. This hypothesis is also consistent with the lack of 
carrier specificity in CRI  ADs dominance of T-dependent antibody responses (11). 
One potential objection to this hypothesis is that Woodland and Cantor (5) were 
able to isolate CRP-specific helpers on idiotype-coated plates, suggesting that the 
helpers are specific for idiotype alone, This objection can be countered in two 
ways. First, it is possible that the helpers have sufficient avidity for the idiotope 
itself to  stick  to  idiotype-coated plates  but  still  require  ABA  for  activation. HORNBECK  AND  LEWIS  67 
Second, the idiotype used to coat the plates was purified on ABA columns, and 
it  is  possible  that  some  ABA  desorbed  with  the  antibody.  In  fact,  we  have 
invariably found small amonts of haptenated proteins in affinity-purified  antibody 
preparations when we have looked with sensitive techniques (unpublished re- 
sults). 
Ifa complex between ABA and a CRI  ^Ds+ VH region is recognized by T helper 
cells, why is this complex more immunogenic than ones made with CRI  ADs- VH 
regions? That  the former complex is  more immunogenic is  suggested by the 
dominance of CRI ^D8  in  anti-ABA responses.  The  simplest possibility  is  that 
idiotype dominance in this system is due to an Ir gene effect, where A/J mice 
are  high  responders  to  the  ABA-CRI  ADs  complex  (59).  In  this  instance,  the 
idiotype-specific helper cell need only be a conventional major histocompatibility 
complex (MHC)-restricted helper cell. The ABA-idiotype complex could be the 
nominal antigen, with the helper restricted by MHC. Alternatively, ABA could 
be the nominal antigen, with the helper restricted by a complex of MHC and 
idiotype. In either case, the result would be preferential expansion of anti-ABA 
clones that express CRI  ^Ds. 
The patterns of CRI ADs expression are also consistent with a suppression model 
of idiotype dominance.  In  this  case,  the complex between CRI ADs and  ABA 
would elicit lower levels of suppression than either complexes between ABA and 
CRI ADs- antibodies, or complexes between CRI ADs and the other haptens. The 
difference in  levels could be accounted for by an Is gene (52) where strain A 
suppressor cells respond poorly to CRI  ADs plus ABA. 
There is evidence that antiidiotypic antibodies (53) and antiidiotypic suppressor 
T  cells (9) can limit the expansion of clones expressing CRI  a.  Under the usual 
conditions of a T-dependent anti-ABA response, these mechanisms may not be 
as effective for CRI  a+ responses as they are for either CRI  a- responses or CRI  ~+ 
responses specific for other epitopes. A corollary of this hypothesis is that CRP 
dominance should be increased by inactivation of suppression. Such a  role for 
antiidiotypic regulation in the CRP system has been confirmed by recent studies 
showing  that  tolerance  of auto-antiidiotypic  antibody  responses  (induced  by 
immunization with CRI  ~) led to the complete dominance of anti-ABA responses 
by this idiotype (53). 
In summary, the patterns of idiotype dominance observed in the CRI  a system 
are consistent with  a  mechanism of idiotype-specific regulation.  The  possible 
mechanisms include: selective expansion of idiotype-positive precursors by idi- 
otype-specific help,  and selective inhibition of idiotype-negative precursors by 
selective suppression. The available data do not permit a choice between these 
two mechanisms; however, they do impose a new constraint on the specificity of 
regulation in the CRI  ~ system: antigen, in addition to idiotype, is an important 
factor in establishing idiotypic dominance. Understanding the mechanism awaits 
further experimentation, but knowing that the specificity may involve antigen 
should make this understanding more accessible. 
Summary 
We describe the recurrence of a cross-reactive idiotope (CRI  ADs) in antibody 
responses to different epitopes, and explore factors leading to its dominance in 
some responses, but not others. Serological and genomic DNA analyses showed 68  IDIOTYP1C DOMINANCE IN  THE  ANTIARSONATE RESPONSE 
that CRI  ADs is a marker of the CRI  a heavy chain variable region (VH) that encodes 
the majority of anti-p-azobenzenearsonate (anti-ABA) antibodies. The independ- 
ence of CRI  ADs from any particular light chain or antigen specificity was under- 
scored by the fact that we could isolate hybridomas that secrete antitrinitrophenyl 
(TNP) antibodies expressing CRI  ADs, with Xl  light chains. CRI  ^Ds is dominant 
in anti-ABA responses, recurrent but nondominant in anti-TNP and anti-chicken 
gammaglobulin responses, and is virtually absent in other antihapten responses, 
including that  to p-azobenzenephosphonate  (ABP),  which  contains  an  ABA- 
cross-reactive component (-5-40%).  Dominance in the anti-TNP response could 
not  be  achieved  by  immunization  with  doubly  haptenated  TNP-ABA-KLH 
(keyhole limpet hemocyanin), where the anti-ABA response was dominated by 
CRI  ADs. These observations suggest that, while the CRI  ADs VH region is necessary 
for idiotypic dominance, it is not sufficient. Apparently, an additional specificity 
is  required.  Since  immunization with  ABA  calls  up  anti-ABP  antibodies  that 
express CRI  ADs, but not vice versa, it is possible that the additional specificity is 
ABA itself. This possibility imposes a  new constraint on  the specificity of the 
putative idiotype-specific regulation that may establish dominance in the CRI  a 
system. 
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